Company: RGNX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-268095
Chunk: 1

Company: REGENXBIO Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
 no shares issued   and outstanding at September 30, 2025 and December 31, 2024

     —

     —

     Common stock; $0.0001 par value; 100,000 shares authorized at September 30, 2025    and December 31, 2024; 50,619 and 49,549 shares issued and outstanding at    September 30, 2025 and December 31, 2024, respectively

     5

     5

     Additional paid-in capital

     1,220,977

     1,192,536

     Accumulated other comprehensive loss

     (652
     )

     (741
     )

     Accumulated deficit

     (1,058,878
     )

     (932,149
     )

     Total stockholders’ equity

     161,452

     259,651

     Total liabilities and stockholders’ equity
      
     $
     525,203

     $
     465,989

The accompanying notes are an integral part of these unaudited consolidated financial statements.